NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT03109158 · COMPLETED
Trial details
- NCT number
- NCT03109158
- Sponsor
- NanoCarrier Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2019-03-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.